[Editors' Choice] Immunomodulation in the front, bone-binding in the back
Zoledronic acid–tethered nanoparticles bind remodeling bone, polarize macrophages, and reduce osteoclasts to prevent breast cancer–induced osteolysis.
Source: Science Translational Medicine - Category: Biomedical Science Authors: Kerr, B. A. Tags: Editors ' Choice Source Type: research
More News: Biomedical Science | Breast Cancer | Cancer | Cancer & Oncology | Nanotechnology | Reclast | Science | Zometa